Understanding the evidence around your product, competitors and the disease area is crucial for you to be to able define and deliver your brand strategy and identify any evidence gaps.
JB Medical are experts in identifying evidence and advising on strategic direction.
Health Technology Appraisal is a key stage in gaining market access and you will need to generate evidence to support your submissions.
JB Medical understand the needs of HTA organisations and are experienced in developing evidence to the highest possible standards.
Communicating your product’s value to policy makers, payors and prescribers is crucial for market access.
JB Medical understands the needs of each customer and is experienced in communicating a product’s value to each audience using credible and compelling language.
Understanding the ways in which your idea or pre-proof of concept device could benefit and be adopted by healthcare will allow you to develop the technology most likely to lead to commercial success.
JB Medical are experts in understanding the clinical and financial barriers facing innovative healthcare value propositions and identifying the pricing envelope in which your device will eventually need to be manufactured.
With proof-of-concept now established, you will need to generate evidence that your device meets or exceeds certain performance limits.
JB Medical can help you understand what performance claims you should aspire to and support you to collect the evidence you require for market readiness, including medical device regulatory approval and peer-reviewed publications on technological performance
With your device soon to be or already on the market, you will be eager to convert those years of R&D into commercial sales.
JB Medical understands the options for increasing market appetite for your device (Health Technology Appraisal, NICE Medtech Innovation Briefing, etc.), and is experienced in leading on or supporting this work.
We also understand the presentation of your clinical and cost-saving evidence that will be most effective in persuading clinicians, commissioners and market influencers to commission your technology.
We've just published a paper in the Journal of Medical Economics showing that adding the Parkinson’s KinetiGraph (the PKG, a wrist-worn movement recording device that collates continuous, objective, data during daily activities in people with Parkinson’s disease (PD) providing a report for clinicians) to standard monitoring of PD is a cost-effective option.
We are super proud to have been involved in writing this White Paper with the World Economic Forum looking at how global sharing of data on rare diseases could provide benefits to diagnosis, management and treatment, clinical trials and personal well-being.
DIASMOKE is a randomised study looking at the long-term health impact of reducing exposure to cigarette smoke by switching to e-cigarettes.
Third Floor
New Mill Business Hub
Bakers Mill
Great Cornard
Sudbury
Suffolk
CO10 0GG
